Blogs for March 2018

Bio-Techne Launches MimEX GI for 3-D Cell Culturing of the Gastrointestinal Tract

Thursday, March 29, 2018 - 09:40
Press Release Bio-Techne

Bio-Techne Launches MimEX GI for Accessible 3-D Cell Culturing of the Gastrointestinal Tract

Bio-Techne is proud to announce the release of MimEX GI, a 3-D cell culturing platform for the generation of gastrointestinal tissue.

Bio-Techne receives CiteAb Researchers Choice Award 2018
Human Ascending Colon Tissue Generated Using MimEX GI Reagents and Media.

This new product line utilizes the unique...

Bio-Techne Go Everywhere Travel Grant - February 2018 Recipient Selected!

Wednesday, March 28, 2018 - 10:00
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the February 2018 grant is Daria Blokhina, a PhD Student in the Department of Pharmacology at the University of Helsinki in Finland!

...

Webinar - GMP Raw Materials for Cell Therapy: What, When, How?

Wednesday, March 28, 2018 - 09:38

Join our panel of experts Jean Stanton (J&J), John Tomtishen (Novartis), Dr. Sadik Kassim (Mustang Bio), and Dr. Diane Wotta (Bio-Techne) as they discuss: what GMP really means in the context of raw materials and ancillary reagents; the quality of raw materials required along the commercialization pathway; when to start using GMP materials; and the current regulatory landscape.

Learn more about R&D Systems GMP Proteins

Stem Cells in the News - April 2018

Tuesday, March 27, 2018 - 09:45
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Futurism

A team of researchers at the University of Cambridge are developing an innovative way to repair heart tissue after a major heart attack: stem cell patches! Cardiomyocytes are...

Engineering iPSC-derived Natural Killer Cells for Enhanced Efficacy of Cancer Therapies

Friday, March 23, 2018 - 08:48

In this webinar, Professor Bruce Walcheck discusses current approaches to augment antibody-dependent cell-mediated cytotoxicity (ADCC) by Natural Killer (NK) cells as therapies to treat cancer. This webinar also includes exciting research from his lab focused on generating enhanced versions of CD16A, an Fc receptor expressed by NK cells that recognizes tumor-targeting mAbs. Finally, his discussion covers the genetic manipulation of induced pluripotent stem cells (iPSCs) to derive NK cells engineered to express modified CD16A, and their potential for improving the efficacy of tumor-targeting therapeutic mAbs.

Key Topics:

  • Current approaches using NK cells as therapies to treat cancer
  • Augmenting ADCC using NK cells
  • Genetic manipulation of iPSCs to derive engineered NK cells
  • Generating enhanced...

New Collection of Platelet Activation Pathways

Thursday, March 22, 2018 - 08:42
Stem Cells in the News

Our website has a new set of interactive pathways that outline platelet activation, with each pathway focusing on a specific aspect of the process. Links within each pathway take you to our relevant product offerings to help you carry out the next steps in your platelet research. You’ll find recombinant proteins, antibodies, small molecules, and peptides, plus single- and multi-analyte immunoassays. Once you start clicking through our pathways, you’ll find some great tools and maybe some new ideas, too.

To navigate the pathways, click on the blue tabs at the left. They allow you to jump from one pathway to another. You can browse our complete collection of pathways here.

  • The...

5 Reasons Why the R&D Systems Human Amyloid beta (aa1-40) and (aa1-42) Quantikine® ELISA Kits are the Best Kits on the Market

Friday, March 16, 2018 - 15:06
Benefits of R&D Systems Amyloid beta Quantikine ELISA Kits

The amyloid cascade hypothesis theorizes that the excessive accumulation of Amyloid beta (A-beta) peptides in the brain are the initiating factor for the development of Alzheimer’s disease (AD). Specifically, that aggregates of A-beta peptides, which are formed following cleavage of the Amyloid Precursor Protein (APP), instigate a series of events that leads to neurodegeneration and, eventually, AD. This hypothesis arose from the observation that the plaques identified in brains afflicted with AD were composed largely of A-beta peptides, and was further supported by the finding that many AD risk and deterministic genes coded...

Stem Cells in the News - March 2018

Monday, March 5, 2018 - 08:20
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Drug Target Review

A recent study in mice from Stanford University suggests that...

MimEX™ Tissue Model Systems

Friday, March 2, 2018 - 13:29

This video provides an overview of MimEX™ Tissue Model Systems, a next-generation 3-dimensional (3-D) cell culture platform for the generation of ex vivo epithelial-derived organ tissue. Learn the basics about how to incorporate this model system into your research, including how it compares to existing 3-D cell culture and organoid models. MimEX™ Tissue Model Systems harnesses the unique characteristics of adult ground-state epithelial stem cells to generate ex vivo organ tissue that recapitulates native cytoarchitecture and mimics physiological attributes of the desired organ. Consisting of optimized media and reagents, MimEX™ Tissue Model Systems provides an alternative to current 3-D cell culture modes, such as organoids, with the added benefit of...